Poppenberg, Kerry E.
Zebraski, Haley R.
Avasthi, Naval
Waqas, Muhammad
Siddiqui, Adnan H.
Jarvis, James N.
Tutino, Vincent M.
Article History
Received: 10 December 2020
Accepted: 2 June 2021
First Online: 16 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: KEP, HRZ, NA, MW—None. AHS—Financial Interest/Investor/Stock Options/Ownership: Amnis Therapeutics, Apama Medi- cal, BlinkTBI, Inc, Buffalo Technology Partners, Inc., Cardinal Health, Cerebrotech Medical Systems, Inc, Claret Medical, Cognition Medical, Endostream Medical, Ltd, Imperative Care, International Medical Distribution Partners, Rebound Therapeutics Corp., Silk Road Medical, StimMed, Synchron, Three Rivers Medi- cal, Inc., Viseon Spine, Inc. Consultant/Advisory Board: Amnis Therapeutics, Boston Scientific, Canon Medical Systems USA, Inc., Cerebrotech Medical Systems, Inc., Cerenovus, Claret Medical, Corindus, Inc., Endostream Medical, Ltd, Guidepoint Global Consulting, Imperative Care, Integra, Medtronic, Micro- Vention, Northwest University—DSMB Chair for HEAT Trial, Penumbra, Rapid Medical, Rebound Therapeutics Corp., Silk Road Medical, StimMed, Stryker, Three Rivers Medical, Inc., VasSol, W.L. Gore & Associates. National PI/Steering Committees: Cerenovus LARGE Trial and ARISE II Trial, Medtronic SWIFT PRIME and SWIFT DIRECT Trials, MicroVention FRED Trial & CONFIDENCE Study, MUSC POSITIVE Trial, Penumbra 3D Separator Trial, COMPASS Trial, INVEST Trial. Principal investigator: Cummings Foundation grant. JNJ—Principal Investigator: R21-AR071878. VMT—Principal investigator: National Science Foundation Award No. 1746694 and NIH NINDS award R43 NS115314-0. Grant funding from: Brain Aneurysm Foundation grant, Centers for Advanced Technology grant (through NY Empire State Development), and Cummings Foundation. Co-founder: Neurovascular Diagnostics, Inc.